Lilly to Acquire Morphic to Improve Outcomes for Patients with ...
WEBJul 8, 2024 · Lilly will commence a tender offer to acquire all outstanding shares of Morphic for a purchase price of $57 per share in cash (an aggregate of approximately $3.2 billion) payable at closing. The transaction has been approved …
Lilly Completes Acquisition of Morphic to Improve Outcomes and …
WEBAug 16, 2024 · Lilly's tender offer to acquire all of the issued and outstanding shares of common stock of Morphic (the "Shares"), at a purchase price of $57 per Share, net to the stockholder in cash, without interest thereon and subject to any applicable tax withholding, expired as scheduled at one minute past 11:59 p.m., Eastern time, on Aug. 15, 2024 and ...
Lilly inks $3.2B Morphic buyout to take on Takeda in IBD - Fierce …
WEBJul 8, 2024 · Eli Lilly has agreed to buy Morphic for $3.2 billion, giving the Big Pharma control of an oral, midphase challenger to Takeda’s injectable inflammatory bowel disease blockbuster Entyvio.
Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Nearly
WEBLilly has agreed to pay $57 a share for Morphic, or a 79% premium to the stock’s closing price of $31.84 on Friday. The deal is expected to close in the third quarter.
Eli Lilly to Buy Morphic Holding for $3.2 Billion - WSJ
WEBJul 8, 2024 · Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
Lilly beefs up bowel disease drug portfolio with $3.2 bln Morphic …
WEBJul 8, 2024 · Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and expanding its footprint...
Eli Lilly Buys Morphic for $3.2B - Yahoo Finance
WEBJul 8, 2024 · Eli Lilly said it would buy Morphic for roughly $3.2 billion or $57 per share, a nearly 80% premium to Friday's closing price. Morphic is developing a treatment for inflammatory bowel disease....
Eli Lilly to pay $3.2 billion in cash to buy this biotech with an IBD ...
WEBJul 8, 2024 · Shares of Morphic Holding Inc. rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly & Co. in a cash deal valued at about $3.2 billion. Lilly...
Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal
WEBJul 8, 2024 · Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline.
Eli Lilly Buys Morphic For $3.2 Billion - Forbes
WEBJul 8, 2024 · Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced Monday, a transaction that includes an experimental medication for ...
- Some results have been removed